Ensysce Biosciences Inc (ENSC)

Jul 22, 2025

What analysts say about Ensysce Biosciences Inc. stockConsistently profitable trades - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com

Jul 22, 2025

Jul 22, 2025

Ensysce Biosciences Inc. Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Ensysce Biosciences Inc. a good long term investmentConsistent wealth multiplication - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Ensysce Biosciences Inc. stock priceRobust financial gains - jammulinksnews.com

Jul 22, 2025

Jul 16, 2025

Ensysce Biosciences initiates Phase 3 study of PF614 - TipRanks

Jul 16, 2025

Jul 16, 2025

FDA-Reviewed Phase 3 Trial Begins: Revolutionary Opioid Promises Pain Relief Without Abuse Risk - Stock Titan

Jul 16, 2025

Jul 15, 2025

What makes Ensysce Biosciences Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025

Jul 15, 2025

Why Ensysce Biosciences Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 15, 2025

Jul 15, 2025

How Ensysce Biosciences Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser

Jul 15, 2025

Jul 15, 2025

NAVY(boat pilot token) Tokenomics ExplainedHigh Return Potential - Newser

Jul 15, 2025

Jul 12, 2025

Where are the Opportunities in (ENSC) - news.stocktradersdaily.com

Jul 12, 2025

Jul 08, 2025

Travere Therapeutics (NASDAQ:TVTX) and Ensysce Biosciences (NASDAQ:ENSC) Head to Head Comparison - Defense World

Jul 08, 2025

Jun 24, 2025

FDA-Designated Breakthrough Pain Drug Advances: New Solution to Opioid Overdose Crisis Shows Promise - Stock Titan

Jun 24, 2025

Jun 21, 2025

(ENSC) Investment Analysis - news.stocktradersdaily.com

Jun 21, 2025

Jun 15, 2025

Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World

Jun 15, 2025

Jun 11, 2025

Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan

Jun 11, 2025

Jun 11, 2025

(ENSC) On The My Stocks Page - news.stocktradersdaily.com

Jun 11, 2025

Jun 07, 2025

Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World

Jun 07, 2025

Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa

Jun 05, 2025

Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor - Investing.com

Jun 05, 2025

Jun 04, 2025

Ensysce Flat on Receiving Grant - Baystreet.ca

Jun 04, 2025

Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia

Jun 04, 2025

Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada

Jun 04, 2025

Jun 04, 2025

Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus

Jun 04, 2025

Jun 04, 2025

Revolutionary Opioid With Built-in Overdose Protection Secures $5.3M NIH Grant After FDA Breakthrough Status - Stock Titan

Jun 04, 2025

Jun 01, 2025

Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World

Jun 01, 2025

May 17, 2025

Zacks Small Cap Analysts Boost Earnings Estimates for ENSC - Defense World

May 17, 2025

May 16, 2025

Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025

May 15, 2025

Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks

May 15, 2025

May 14, 2025

Ensysce Biosciences: Is Now the Time to Bet on a Turnaround? - AInvest

May 14, 2025

May 13, 2025

Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan

May 13, 2025

May 12, 2025

Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan

May 12, 2025